| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7091236 | CASPER PHARMA LLC | Method for increasing the bioavailability of glycopyrrolate |
Apr, 2024
(9 days ago) | |
Robinul Forte is owned by Casper Pharma Llc.
Robinul Forte contains Glycopyrrolate.
Robinul Forte has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Robinul Forte are:
- US7091236
Robinul Forte is available in tablet;oral dosage forms.
Robinul Forte can be used as for use as adjunctive therapy in the treatment of peptic ulcer.
The generics of Robinul Forte are possible to be released after 24 April, 2024.
Drugs and Companies using GLYCOPYRROLATE ingredient
Treatment: For use as adjunctive therapy in the treatment of peptic ulcer
Dosage: TABLET;ORAL
How can I launch a generic of ROBINUL FORTE before it's drug patent expiration?
More Information on Dosage
ROBINUL FORTE family patents
